Home/Filings/4/0001209191-23-033835
4//SEC Filing

Niederhuber John 4

Accession 0001209191-23-033835

CIK 0001671584other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:44 PM ET

Size

9.3 KB

Accession

0001209191-23-033835

Insider Transaction Report

Form 4
Period: 2023-06-01
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2023-06-01297298 total
    Common Stock (297 underlying)
  • Exercise/Conversion

    Common Stock

    2023-06-01+2972,111 total
  • Award

    Restricted Stock Unit

    2023-06-02+3,5713,571 total
    Common Stock (3,571 underlying)
Footnotes (3)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
  • [F3]The RSUs vest in full on the first anniversary of the date of grant.

Issuer

Aptevo Therapeutics Inc.

CIK 0001671584

Entity typeother

Related Parties

1
  • filerCIK 0001501240

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:44 PM ET
Size
9.3 KB